You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

abiraterone therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer Trial in Tampa (Abiraterone Acetate)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jan 3, 2023

High-risk Prostate Cancer, Neoadjuvant Therapy Trial in Shanghai (Abiraterone acetate, Fluzoparib, Prednisone)

Recruiting
  • High-risk Prostate Cancer
  • Neoadjuvant Therapy
  • Abiraterone acetate
  • +4 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 6, 2022

Prostate Cancer Trial in Nanjing (Abiraterone Acetate, Prednisone, Goserelin 10.8 mg)

Active, not recruiting
  • Prostate Cancer
  • Abiraterone Acetate
  • +2 more
  • Nanjing, Jiangsu, China
    Department of Urology, Drum Tower Hospital, Medical School of Na
Dec 14, 2022

Neoadjuvant Therapy Trial in Nanjing (pamiparib, abiraterone, prednisone)

Recruiting
  • Neoadjuvant Therapy
  • Nanjing, Jiangsu, China
  • +2 more
Jan 3, 2023

High-Risk Prostate Cancer Trial in Portland (Capivasertib, abiraterone acetate)

Not yet recruiting
  • High-Risk Prostate Cancer
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jan 17, 2023

Metastatic Cancer, Tumor, Prostate Trial in Bronx (Abiraterone acetate, Apalutamide, Enzalutamide)

Not yet recruiting
  • Metastatic Cancer
  • Neoplasm, Prostate
  • Abiraterone acetate
  • +2 more
  • Bronx, New York
    James J. Peters VA Medical Center
Jun 16, 2022

Castration-resistant Prostate Cancer Trial in Wuxi (Polaprezinc, Abiraterone)

Enrolling by invitation
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Sep 18, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Malignant Tumor in the Bone, Metastatic Prostate Carcinoma Trial in Seattle

Active, not recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +7 more
  • Antiandrogen Therapy
  • +3 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 8, 2022

Castration-Resistant Prostatic Cancer, Androgen-Independent Prostatic Cancer, Androgen-Insensitive Prostatic Cancer Trial in

Recruiting
  • Castration-Resistant Prostatic Cancer
  • +4 more
  • Orange City, Florida
  • +1 more
Nov 23, 2022

Congenital Adrenal Hyperplasia Trial in United States (Abiraterone acetate, Placebo, Hydrocortisone)

Withdrawn
  • Congenital Adrenal Hyperplasia
  • Abiraterone acetate
  • +3 more
  • Los Angeles, California
  • +3 more
Jan 30, 2023

Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy Trial in France (Abiraterone)

Completed
  • Biochemically-relapsing Prostate Adenocarcinoma Following Radical Prostatectomy
  • Bordeaux, France
  • +4 more
May 18, 2022

Learn About Novel Hormonal Therapies for Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Nov 21, 2023

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IV Prostate Cancer AJCC v8 Trial in Duarte

Recruiting
  • Castration-Sensitive Prostate Carcinoma
  • +4 more
  • Abiraterone Acetate
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Oct 7, 2022

Prostatic Tumors, Castration-Resistant Trial in Leiden (Patient-specific adaptive therapy, Abiraterone acetate, Enzalutamide)

Recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Patient-specific adaptive therapy
  • +2 more
  • Camperdown, New South Wales, Australia
  • +6 more
Jan 11, 2023

Learn About Novel Hormonal Therapies in People With Metastatic

Not yet recruiting
  • Prostatic Neoplasms
  • Novel hormonal therapy
  • New York, New York
    Pfizer Inc
Oct 2, 2023

Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))

Recruiting
  • Oligoprogressive
  • Castration-Resistant Prostate Cancer
  • Stereotactic Body Radiation Therapy (SABR)
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Apr 9, 2021

Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +2 more
  • Baltimore, Maryland
  • +3 more
Mar 30, 2022

Metastatic Castration-resistant Prostate Cancer Trial in China (olaparib, abiraterone acetate)

Recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • Beijing, China
  • +35 more
Aug 9, 2022

Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

Recruiting
  • Prostate Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 27, 2021

Oligometastatic Prostate Carcinoma Trial in China (ADT combined with abiraterone, neoadjuvant hormone and RT)

Not yet recruiting
  • Oligometastatic Prostate Carcinoma
  • ADT combined with abiraterone
  • neoadjuvant hormone and RT
  • Hefei, Anhui, China
  • +5 more
Jan 28, 2023

Prostatic Tumors, Castration-Resistant, Drug Therapy, Combination Trial in Chengdu (TQB3616 Capsules Combined With Abiraterone

Not yet recruiting
  • Prostatic Neoplasms, Castration-Resistant
  • Drug Therapy, Combination
  • TQB3616 Capsules Combined With Abiraterone Acetate Plus Prednisone
  • Chengdu, Sichuan, China
    West China Hospital
Dec 12, 2021

Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)

Recruiting
  • Prostatic Neoplasms
  • New York, New York
    Memorial Sloan-Kettering Cancer Center
Jul 21, 2022

Prostate Cancer Trial in Durham, Houston (Abiraterone acetate, Androgen deprivation, Radiation Therapy)

Active, not recruiting
Has Results
  • Prostate Cancer
  • Abiraterone acetate
  • +3 more
  • Durham, North Carolina
  • +2 more
Oct 27, 2021

Metastatic Castration-resistent Prostate Cancer Trial in Napoli (Docetaxel, Abiraterone Acetate or Enzalutamide)

Active, not recruiting
  • Metastatic Castration-resistent Prostate Cancer
  • Napoli, Italy
    Istituto Nazionale dei Tumori , Oncologia Medica - Dipartimento
Jul 27, 2021